VistaGen Therapeutics Inc (NASDAQ:VTGN)
| 0.80 Delayed Data As of Aug 03 |  -0.125 / -13.44%Today’s Change | 0.29 Today|||52-Week Range 1.49 | +15.99% Year-to-Date |
Latest VTGN News | Press Releases
| VistaGen under pressure on proposed public offering Jul 31 / Seeking Alpha - Paid Partner Content | IPO Update: Vasta Platform Pursues $306 Million U.S. IPO Jul 27 / Seeking Alpha - Paid Partner Content |
| VistaGen readies equity offering Jul 31 / Seeking Alpha - Paid Partner Content |
Today’s Trading
| Previous close | 0.93 |
| Today’s open | 0.78 |
| Day’s range | 0.76 - 0.82 |
| Volume | 4,761,271 |
| Average volume (3 months) | 1,312,578 |
| Market cap | $52.2M |
Data as of 3:59pm ET, 08/03/2020
Growth & Valuation
| Earnings growth (last year) | +44.24% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CDMOPAvid Bioservices Inc | -0.17 | -0.68% |
| MBOTMicrobot Medical Inc | +0.17 | +2.53% |
| SEELSeelos Therapeutics ... | -0.07 | -6.03% |
| IMMPImmutep Ltd | -0.06 | -4.48% |
Data as of 3:59pm ET, 08/03/2020
Financials
| Next reporting date | August 18, 2020 |
| EPS forecast (this quarter) | -$0.07 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$20.8M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters South San Francisco, California |
Forecasts
